Table 1.
Patients’ baseline clinical characteristics.
| Variable | Baseline Values |
|---|---|
| Female/male | 35/45 (44%/66%) |
| Age (years) | 39 ± 14 |
| SBP (mmHg) | 131 ± 16 |
| DBP (mmHg) | 80 ± 11 |
| MAP (mmHg) | 95 ± 12 |
| NLR | 2.4 ± 1.5 |
| PLR | 140 ± 59 |
| Total cholesterol (mg/dL) | 258 ± 104 |
| Triglycerides(mg/dL) | 172 ± 91 |
| Uric acid (mg/dL) | 6.6 ± 1.7 |
| Fasting glucose (mg/dL) | 93 ± 11 |
| Serum albumin (g/dL) | 3.5 ± 0.9 |
| Total protein (g/dL) | 6.0 ± 1.2 |
| Serum creatinine(mg/dL) | 1.4 ± 1.4 |
| eGFR (mL/min/1.73 m2) | 68 ± 24 |
| UPCR(g/g) | 1.9 ± 1.6 |
| Erythrocyturia—moderate | 33 (41%) |
| Erythrocyturia—severe | 28 (35%) |
| Hypertension | 39 (49%) |
| ACEI treatment | 52 (65%) |
| Prednisone use | 18 (23%) |
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; eGFR, estimated glomerular filtration rate; UPCR, urine protein-to-creatinine ratio; ACEI, angiotensin-converting enzyme inhibitor.